| Application no. and date | 17814267.5 (espacenet) (Federated) (European Patent Register), 20170619 | | Patent/reg. no. and date | DK/EP 3472314, 20210505 | | Publication date | 20190424 | | Priority no. and date | US 201662351841 P, 20160617 | | EP pub. no. and date |
EP 3472314 20190424 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | 1599195 | | Inventor | KARBARZ, Mark, c/o Portola Pharmaceuticals Inc.
270 E. Grand Ave.
Suite 22
South San Francisco, California 94080, US,
CONLEY, Pamela B., c/o Portola Pharmaceuticals Inc.
270 E. Grand Ave.
Suite 22
South San Francisco, California 94080, US,
LU, Genmin, c/o Portola Pharmaceuticals Inc.
270 E. Grand Ave.
Suite 22
South San Francisco, California 94080, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 1/22 (2006.01) , C12N 9/64 (2006.01) | | Title | FREMSTILLING AF FAKTOR-XA-DERIVATER | | Int. application no. | US2017038169 | | Int. publication no. | WO2017219034 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
